Coya Therapeutics, Inc. (COYA) stock
COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3017% above fair value
$3.02+0.02 (+0.67%)
Close on Nov 17, 2026Market cap $70.84MP/E –Yield –
Earnings
Coya Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Mar 15, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$200.00K
-94.4% on a year earlier
EPS, Q3 FY2026
-$0.45
-$0.13 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Coya Therapeutics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 15, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 10, 2026before the open | $200.00K | -94.4% | -$0.45 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 11, 2026before the open | $200.00K | 0.0% | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 12, 2026before the open | $300.00K | +16.3% | -$0.32 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 16, 2026before the open | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 12, 2025before the open | $3.60M | – | -$0.13 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 12, 2025before the open | $200.00K | -94.1% | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 13, 2025before the open | $257.88K | +103.3% | -$0.44 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 18, 2025before the open | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 6, 2024before the open | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 12, 2024before the open | $3.40M | – | -$0.19 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 9, 2024after the close | $126.84K | – | -$0.35 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 19, 2024before the open | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 8, 2023before the open | – | – | -$0.34 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023before the open | – | – | -$0.31 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 10, 2023before the open | – | – | -$0.28 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 29, 2023after the close | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Coya Therapeutics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Coya Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Coya Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Update
- Results
- Update
- Update
- Results
- Results
- Results
- Results
- Update
- Update
- Update
See a number that looks wrong?